Senores Pharmaceuticals Ltd. has inaugurated its newly established Greenfield Active Pharmaceutical Ingredient (API) plant on 26 February 2025 at Mehsana, Gujarat, India, and started production activities too. This strategic expansion marks a milestone in the company’s growth, while improving its capabilities in the pharmaceutical manufacturing sector.
About Senores Pharmaceuticals Ltd.
Senores Pharmaceuticals Ltd. is an international, research-oriented pharmaceutical company that is involved in the manufacturing and development of high-quality pharmaceutical products. With emphasis on innovation and excellence, the company serves diverse sets of markets through a broad portfolio of APIs and finished dosage forms. The company is committed to improving healthcare outcomes by offering effective and reliable pharmaceutical solutions.
A Strategic Expansion in Gujarat
Located at Survey No. 1503, Rajpur, Kadi, Mehsana – 382715, the facility occupies nearly 230,000 square feet of area. Having an installed capacity of nearly 100 metric tons per year, the plant is Senores Pharmaceuticals’ second API manufacturing facility that significantly increases its current production capacity. The company will manufacture all its APIs, including Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, Imatinib Mesylate, Letrozole, Nicardipine Hydrochloride, Mesalamine, Oxcarbazepine, Rivaroxaban, Tamsulosin Hydrochloride, and Tofacitinib Citrate, in its newly established plant at Mehsana, Gujarat, India.
Click to get more info on India API Market (Including Full TOC, Graphs & Charts, Table & Figures) @
https://api.omrglobal.com/report-gallery/india-api-market/
The establishment of this plant is part of Senores Pharmaceuticals’ efforts to fulfill increasing domestic and international demand for quality APIs. By broadening its manufacturing base, the company is ambitious to strengthen its position in the highly competitive pharma industry.
Making Senores Pharmaceuticals Ltd. More Competitive in Regulated Markets
The new API facility will be utilized to serve regulated markets, mainly focusing on Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services. The move is made to expand Senores Pharmaceuticals’ range of offerings and its position in the global pharmaceutical landscape.
Swapnil Shah, Managing Director of Senores Pharmaceuticals Ltd., said on the inauguration: “We are delighted to commence operations at our Greenfield state-of-the-art API facility at Mehsana. Commissioning of this API facility will help Senores broaden its offerings and strengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMO business.”
Commitment to Quality and Innovation
Senores Pharmaceuticals has always put a priority on quality and innovation in its operations. The new facility features innovative manufacturing technologies and follows high-quality control measures, while ensuring the production of high-standard APIs. The commitment by Senores Pharmaceuticals towards excellence positions them to effectively serve the emerging demand of the pharmaceutical industry.
The Mehsana facility’s strategic location offers many logistical advantages, enables efficient distribution, and helps in the supply chain management of the company. This improves Senores Pharmaceuticals’ capabilities to deliver products quickly to different markets, therefore enhancing operational efficiency and increasing customer satisfaction.
Future Outlook
The establishment of the Greenfield API plant in Mehsana, Gujarat, marks a milestone in Senores Pharmaceuticals’ growth strategy. In strengthening its manufacturing capacity, the company is poised to take advantage of increasing opportunities in the pharmaceutical industry. The expanded capacity will allow Senores Pharmaceuticals to address growing market needs and reinforce its dedication to producing high-quality drugs.
As the business expands, it is committed to maintaining compliance, the highest standards of quality, and customer service. The new building is likely to be a driving force in Senores Pharmaceuticals’ future success and contribute to the pharmaceutical industry’s progress.
Click to get more info on several API Markets (Including Full TOC, Graphs & Charts, Table & Figures) @
https://api.omrglobal.com/report-gallery/anastrozole-market/
https://api.omrglobal.com/report-gallery/fluoxetine-hydrochloride-market/
